Dermal Exposure to a Compounded Pain Cream Resulting in Severely Elevated Clonidine Concentration

Journal of Medical Toxicology

Volumn 10, Issue 1, 2014, Pages 61-64

  Pomerleau, Adam C ^a,b,c   Gooden, Casey E ^b   Fantz, Corinne R ^b   Morgan, Brent W ^a,b  

^a Georgia Poison Center   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Department of Pathology and Laboratory Medicine Emory University School of Medicine ^*  (United States)

Author keywords

Adrenergic alpha 2 receptor agonists; Drug administration; Imidazoline receptors; Topical; Toxicology

Indexed keywords

CLONIDINE; CORTICOSTEROID; HYDRALAZINE; SKIN CREAM; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; DRUG COMBINATION;

ADULT; ARTICLE; BRADYCARDIA; CASE REPORT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONSCIOUSNESS DISORDER; DISORIENTATION; DRUG EXPOSURE; DRUG OVERDOSE; EXPOSURE; FOLLOW UP; HUMAN; INTUBATION; MALE; MYDRIASIS; SLURRED SPEECH; SUBARACHNOID HEMORRHAGE; YOUNG ADULT; BLOOD; DRUG COMBINATION; DRUG FORMULATION; HYPERTENSION; INTRADERMAL DRUG ADMINISTRATION; MEDICATION COMPLIANCE; NEUROTOXICITY SYNDROMES; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ADULT; ANALGESICS; BRADYCARDIA; CLONIDINE; DRUG COMBINATIONS; DRUG COMPOUNDING; DRUG OVERDOSE; HUMANS; HYPERTENSION; MALE; MEDICATION ADHERENCE; NEUROTOXICITY SYNDROMES; SKIN CREAM; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84897534194     PISSN: 15569039     EISSN: 19376995     Source Type: Journal    
DOI: 10.1007/s13181-013-0331-x     Document Type: Article

References (15)

1. Campbell CM, Kipnes MS, Stouch BC et al (2012) Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy. Pain 153(9): 1815-1823.
2. Kobinger W (1978) Central alpha-adrenergic systems as targets for hypotensive drugs. Rev Physiol Biochem Pharmacol 81: 39-100.
3. Frye CB, Vance MA (2000) Hypertensive crisis and myocardial infarction following massive clonidine overdose. Ann Pharmacother 34(5): 611-615.
4. Johnson ML, Visser EJ, Goucke CR (2011) Massive clonidine overdose during refill of an implanted drug delivery device for intrathecal analgesia: a review of inadvertent soft-tissue injection during implantable drug delivery device refills and its management. Pain Med 12(7): 1032-1040.
5. Domino LE, Domino SE, Stockstill MS (1986) Relationship between plasma concentrations of clonidine and mean arterial pressure during an accidental clonidine overdose. B J Clin Pharmacol 21(1): 71-74.
6. Farooqi M, Seifert S, Kunkel S et al (2009) Toxicity from a clonidine suspension. J Med Toxicol 5(3): 130-133.
7. Romano MJ, Dinh A (2001) A 1000-fold overdose of clonidine caused by a compounding error in a 5-year-old child with attention-deficit/hyperactivity disorder. Pediatrics 108(2): 471-472.
8. MacGregor TR, Matzek KM, Keirns JJ et al (1985) Pharmacokinetics of transdermally delivered clonidine. Clin Pharmacol Ther 38(3): 278-284.
9. Prescribing Information (2012) Catapres-TTS(R) transdermal system, clonidine transdermal system. Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT. http://bidocs. boehringer-ingelheim. com/BIWebAccess/ViewServlet. ser?docBase=renetnt&folderPath=/Prescribing+Information/PIs/Catapres+TTS/CatapresTTS. pdf. Accessed 24 May 2013.
10. Baselt RC (2011). Clonidine. In: Disposition of toxic drugs and chemicals in Man, 9th edn, Seal Beach: Biomedical Publications. pp. 378-380.
11. Harris JM (1990) Clonidine patch toxicity. DICP 24(12): 1191-1194.
12. Killian CA, Roberge RJ, Krenzelok EP et al (1997) "Cloniderm" toxicity: another manifestation of clonidine overdose. Pediatr Emerg Care 13(5): 340-341.
13. Raber JH, Shinar C, Finkelstein S (1993) Clonidine patch ingestion in an adult. Ann Pharmacother 27(6): 719-722.
14. Food and Drug Administration (2013) Pharmacy compounding and the FDA: Questions and answers. http://www. fda. gov/Drugs/GuidanceComplianceRegulatoryInformation/PharmacyCompounding/ucm339764. htm. Accessed 19 Aug 2013.
15. Temple TR, Nelson AA (1975) An evaluation of the quality of pharmaceutical care: a study of the pharmacist's compounding behavior. Drug Intell Clin Pharm 9(11): 591-595.